Preclinical evaluation of Brincidofovir in glioblastoma demonstrates improved long term-survival and cytomegalovirus-dependent and independent effects
Noe B. Mercado, Philippa C. Vaughn-Beaucaire, William M. Hawkins, Andrea Schmidt, Jasmine S. Clark, Michelle Shub, Mariia Vorobeva, Yovany Padilla, Austin Jacobson, Ayaan Akhtar, Paola Sundaram, Eleni Panagioti, Eain A. Murphy, James Arthur Lederer, Masatoshi Hazama, , Sean Edward Lawler
This study evaluates Brincidofovir's effects on glioblastoma, showing improved survival and both CMV-dependent and independent antitumor activity.
bioRxiv · Aug 21, 2026 · PreprintCancer Biology